PREDICTOM project into early Alzheimer's detection.
Thank you to Siemens Healthineers for hosting the PREDICTOM 2nd general assembly in Erlangen Innovation Center Germany.
Muhdo Health’s CFO Richard Layton was there on behalf of the Muhdo team and had the opportunity to talk with Gaby Marquardt from Siemens Healthineers, Professor Dag Aarsland and Timo Schirmer Director at GE HealthCare.
PREDICTOM - IHI project is a fantastic partnership between 30 partners across 15 countries, which combines bioinformatics and AI to better predict and improve Alzheimer's detection.
A consortium of 30 partners from academia, business, civil society, and hospitals, backed by EUR 21 million in funding (EUR 8 million from the EU, EUR 9 million from industry and EUR 4 million from UKRI), is steering PREDICTOM.
Muhdo Health is at the forefront of pioneering early Alzheimer's detection through our groundbreaking collaboration with the PREDICTOM project. This fantastic partnership combines our expertise in personalised health and genetic/epigenetic profiling with the innovative approach of the PREDICTOM project, which focuses on advanced data analytics and predictive modelling.
This joint initiative signifies a significant leap forward in the quest to tackle Alzheimer's disease and underscores the power of collaborative efforts in advancing healthcare research and innovation.
The consortium includes partners from 15 countries across Europe, Asia and America and is led by Stavanger University Hospital (Norway).
The EU funding is provided through Horizon Europe, while the remaining funding for this project comes from Novo NordiskA/S, GN Hearing A/S, Pharmacoidea Ltd. Hungary, GE HealthCare, Siemens Healthineers, icometrix Nv Belgium, ALZpath Inc. Inc USA, University of Geneva, Altoida, Inc. USA, BrainCheck Inc USA, Muhdo Health Ltd, and UK Dementia Research Institute and Innovation (UKRI).